Source:http://linkedlifedata.com/resource/pubmed/id/15286686
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-9-2
|
pubmed:abstractText |
Cutaneous T-cell lymphomas (CTCL) are rare diseases that, in their advanced stages or in transformation, have a poor prognosis. Autologous stem cell transplantation (Au-SCT) after high-dose therapy has yielded disappointing results. Allogeneic transplantation (allo-SCT) provides the potential advantage of an immune-mediated graft-versus-lymphoma (GVL) effect. Reduced-intensity allo-SCT potentially offers a GVL effect, but with diminished toxicity related to the induction regimen; however, published experience with this approach in CTCL is limited. We report a series of three patients (age 35-49) with advanced, refractory (n=2) or transformed (n=1) CTCL who underwent reduced-intensity allo-SCT in the context of active disease. All three survived the peri-transplant period and, despite later having disease relapse, all exhibited evidence of a GVL effect. Relapses of the disease were in the context of immune suppression for graft-versus-host disease (GVHD), and when immune suppression was reduced, responses were regained. A comparison is made of these results to those in a review of the published literature to date. We conclude that while a GVL can be achieved for CTCL with reduced-intensity allogeneic transplantation, the clinical benefits are short lived and novel approaches are required to obtain sustained remissions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
521-5
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:15286686-Graft vs Tumor Effect,
pubmed-meshheading:15286686-Humans,
pubmed-meshheading:15286686-Infant,
pubmed-meshheading:15286686-Lymphocyte Transfusion,
pubmed-meshheading:15286686-Lymphoma, T-Cell, Cutaneous,
pubmed-meshheading:15286686-Male,
pubmed-meshheading:15286686-Middle Aged,
pubmed-meshheading:15286686-Siblings,
pubmed-meshheading:15286686-Stem Cell Transplantation,
pubmed-meshheading:15286686-Transplantation, Homologous,
pubmed-meshheading:15286686-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation.
|
pubmed:affiliation |
Haematology Service, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|